How state policies on substance use treatment affect healthcare use and opioid overdoses in Medicaid patients
The Effects of States' Substance Use Waivers on Healthcare Utilization and Opioid-related Overdoses Among Medicaid Enrollees with Opioid Use Disorder
This study looks at how different Medicaid rules in each state affect the treatment and recovery of people with opioid use disorder, aiming to find out which policies help more people get the care they need and reduce overdose rates.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10841552 on NIH RePORTER |
What this research studies
This research investigates the impact of state-level Medicaid policies on the treatment and outcomes of individuals with opioid use disorder (OUD). It focuses on how different state waivers influence healthcare utilization and the rates of opioid-related overdoses among Medicaid enrollees. By analyzing data from various states, the study aims to identify which policies are most effective in improving treatment access and reducing overdose incidents. The findings could help inform better healthcare policies for managing OUD.
Who could benefit from this research
Good fit: Ideal candidates for this research are Medicaid enrollees diagnosed with opioid use disorder.
Not a fit: Patients who do not have opioid use disorder or are not enrolled in Medicaid may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare policies that enhance treatment access and reduce opioid overdoses among Medicaid patients.
How similar studies have performed: Previous research has shown that certain state policies can significantly impact treatment outcomes for opioid use disorder, suggesting that this approach has potential for meaningful insights.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Lindner, Stephan Reinhard — Oregon Health & Science University
- Study coordinator: Lindner, Stephan Reinhard
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.